ANAVEX LIFE SCIENCES CORP. (AVXL) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $93.00K; Additional Paid in Capital, Common StockUSD $498.00M; Retained Earnings (Accumulated Deficit)USD $-385.64M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $93.00K; Additional Paid in Capital, Common StockUSD $515.08M; Retained Earnings (Accumulated Deficit)USD $-393.47M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $93.00K; Additional Paid in Capital, Common StockUSD $514.65M; Retained Earnings (Accumulated Deficit)USD $-388.13M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD (m); Common Stock, Value, IssuedUSD $87.00K; Additional Paid in Capital, Common StockUSD $477.23M; Retained Earnings (Accumulated Deficit)USD $-382.45M.
ANAVEX LIFE SCIENCES CORP. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Additional Paid in Capital USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Other USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $93.00K | $498.00M | $-385.64M | $112.45M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $93.00K | $515.08M | $-393.47M | $121.71M | 3 month · $314.00K 6 month · $1.42M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $93.00K | $514.65M | $-388.13M | $126.62M | 3 month · $1.11M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $87.00K | $477.23M | $-382.45M | $94.87M | 12 month · $11.55M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $85.00K | $463.49M | $-372.62M | $90.96M | 3 month · $4.32M 9 month · $7.83M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $85.00K | $459.05M | $-359.38M | $99.76M | 3 month · $1.45M 6 month · $3.50M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $85.00K | $459.01M | $-348.18M | $110.92M | 3 month · $2.06M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $85.00K | $456.25M | $-336.07M | $120.26M | 12 month · $9.44M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $85.00K | $454.24M | $-324.45M | $129.78M | 3 month · $2.49M 9 month · $7.42M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $84.00K | $447.35M | $-312.24M | $134.96M | 3 month · $2.65M 6 month · $4.94M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $82.00K | $437.18M | $-301.69M | $135.57M | 3 month · $2.29M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $82.00K | $434.84M | $-293.07M | $141.85M | 12 month · $16.37M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $81.39K | $429.60M | $-282.92M | $146.75M | 3 month · $3.87M 9 month · $13.18M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $80.24K | $416.73M | $-271.64M | $145.16M | 3 month · $3.97M 6 month · $9.32M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $78.03K | $393.58M | $-258.54M | $135.12M | 3 month · $5.35M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $78.00K | $387.98M | $-245.56M | $142.49M | 12 month · $18.38M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $77.94K | $381.93M | $-231.27M | $150.74M | 3 month · $3.99M 9 month · $12.34M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $77.16K | $371.44M | $-218.91M | $152.21M | 3 month · $4.44M 6 month · $8.35M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $76.16K | $354.76M | $-208.47M | $146.37M | 3 month · $3.91M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $75.92K | $348.33M | $-197.59M | $150.82M | 12 month · $8.23M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | $342.94M | $-185.87M | $157.15M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $70.03K | $251.43M | $-175.69M | $75.81M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | $66.96K | $213.77M | $-167.53M | $46.30M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $0.00 | $62.05K | $186.85M | $-159.68M | $27.24M | 12 month · $4.88M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $0.00 | $60.08K | $178.33M | $-153.71M | $24.68M | 3 month · $1.25M 9 month · $4.22M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $58.67K | $171.96M | $-147.23M | $24.79M | 3 month · $1.70M 6 month · $2.97M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $57.08K | $165.89M | $-139.99M | $25.96M | 3 month · $1.26M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $0.00 | $52.65K | $153.63M | $-133.40M | $20.29M | 12 month · $6.43M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $51.51K | $148.93M | $-131.35M | $21.19M | 3 month · $1.23M 9 month · $5.19M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $48.17K | $138.70M | $-124.27M | $17.18M | 3 month · $1.89M 6 month · $3.96M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | $46.89K | $133.44M | $-116.27M | $19.46M | 3 month · $2.07M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | (m) | $45.94K | $129.38M | $-107.10M | $22.32M | 12 month · $5.52M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | $45.31K | $126.68M | $-103.14M | $23.59M | 3 month · $1.68M 9 month · $4.03M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | $44.58K | $122.72M | $-100.29M | $22.48M | 3 month · $1.23M 6 month · $2.35M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $44.42K | $121.04M | $-95.54M | $25.55M | 3 month · $1.12M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-10-02 | (m) | (m) | (m) | $-89.85M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | $43.33K | $115.69M | $-91.48M | $25.88M | 12 month · $4.14M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | $42.17K | $109.73M | $-86.32M | $23.45M | 9 month · $3.02M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | $41.38K | $104.16M | $-82.71M | $21.49M | 6 month · $1.86M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | $40.67K | $100.30M | $-81.16M | $19.18M | 3 month · $889.27K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | $36.17K | $84.29M | $-78.02M | $6.31M | 12 month · $4.45M | (m) | (m) | 12 month · $4.45M | (m) | (m) | (m) |
| 2016-06-30 | (m) | $35.71K | $79.14M | $-71.51M | $7.67M | 9 month · $666.97K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | $35.70K | $78.91M | $-69.27M | $9.68M | 6 month · $438.71K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | $34.66K | $76.13M | $-67.24M | $11.49M | 3 month · $216.02K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | $32.04K | $74.06M | $-63.28M | $12.81M | 12 month · $1.63M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | $86.22K | (m) | (m) | $6.57M | (m) | $65.03M | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | $64.88K | (m) | (m) | $4.70M | (m) | $59.08M | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $54.81K | (m) | (m) | $473.13K | (m) | $53.14M | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | $11.80K | $50.71M | $-51.17M | $192.63K | 12 month · $637.92K | $52.08M | 12 month · $2.45K | (m) | 12 month · $2.61M | 12 month · $5.99M | 12 month · $221.00K |
| 2014-06-30 | (m) | $38.26K | (m) | (m) | $7.41M | (m) | $49.60M | (m) | (m) | 9 month · $4.01M | (m) | 9 month · $221.00K |
| 2014-03-31 | (m) | $38.26K | (m) | (m) | $8.41M | (m) | $49.60M | (m) | (m) | 6 month · $4.01M | (m) | 6 month · $221.00K |
| 2013-12-31 | (m) | $37.64K | (m) | (m) | $-1.67M | (m) | $39.08M | (m) | (m) | (m) | (m) | 3 month · $221.00K |
| 2013-09-30 | (m) | $37.24K | (m) | (m) | $-2.46M | (m) | $38.64M | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | $30.24K | (m) | (m) | $-3.55M | (m) | $34.60M | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | $30.24K | (m) | (m) | $-3.43M | (m) | $34.60M | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | $30.24K | (m) | (m) | $-3.33M | (m) | $34.60M | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | $30.24K | (m) | (m) | $-2.88M | (m) | $34.60M | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | $30.17K | (m) | (m) | $-2.20M | (m) | $34.52M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | $-2.93M | (m) | $29.33M | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | $-2.48M | (m) | $28.87M | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | $26.57K | (m) | (m) | $-1.14M | (m) | $28.03M | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | $25.92K | (m) | (m) | $-973.45K | (m) | $26.78M | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | $23.52K | (m) | (m) | $-2.96M | (m) | $18.91M | (m) | (m) | (m) | (m) | (m) |
| 2009-09-30 | (m) | (m) | (m) | (m) | $-3.86M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-09-30 | (m) | (m) | (m) | (m) | $-2.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2007-09-30 | (m) | (m) | (m) | (m) | $-462.50K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2006-09-30 | (m) | (m) | (m) | (m) | $-15.51K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2005-09-30 | (m) | (m) | (m) | (m) | $-26.02K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2004-09-30 | (m) | (m) | (m) | (m) | $25.61K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |